Good news from pharmaceutical giant Pfizer. They have announced that the corona vaccine that they have developed with the German BioNTech also seems to work against the more contagious variant of the virus from the United Kingdom. This is shown by the results of a lab study at the University of Texas.
A new variant of the SARS-CoV-2 virus that was first discovered in the United Kingdom in mid-December has been causing panic for some time. Not only is this mutation a lot contagious. There was also the fear that current corona vaccines would not work against it.
Blood from vaccinated people
The latter does not appear to be the case for the corona vaccine from Pfizer and BioNTech. This vaccine is currently the only one administered in Belgium and the rest of the European Union. Recently, Europe also approved the Moderna vaccine and the AstraZeneca / Oxford vaccine will probably follow soon.
To find out whether their vaccine also works against the new, more contagious mutation – known as B117 – the American pharmaceutical company Pfizer conducted a lab test with researchers at the University of Texas. They looked at blood taken from people who have already been vaccinated with the Pfizer / BioNTech vaccine.
“No significant impact”
This showed that the vaccine also offers protection against this new variant. “We have now tested 16 different mutations, and none of them have really had a significant impact. That’s the good news, ”Phil Dormitzer, a scientist at Pfizer, told Reuters on Thursday. “That doesn’t mean the 17th won’t.”
If the latter were the case, Pfizer and BioNTech assume that they can quickly adjust their vaccine if necessary.